EX2 Lecture 6 - Drug Interactions Flashcards

1
Q

what are drug interactions

A

The modification of the effect of one drug by the prior accompanying administration of another drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what things are at risk in drug interactions

A

Risking loss of therapeutic effect, toxicity, unexpected adverse effects, or incompatibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

effect can vary from ____

A

one person to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are risk factors of drug interactions?

A

Polypharmacy,
multiple prescribers,
multiple pharmacies,
genetic make up,
special populations (elderly, critically ill)
drug make up (a small therapeutic index, prodrug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

two or more drugs given together, create what

A

an alteration in effect

can be beneficial or harmful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

carbidopa and levodopa interaction example

A

Carbidopa inhibits peripheral breakdown of levodopa, which means more levadopa crosses the blood brain barrier, giving additional and lengthened time and ability in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

warfarin drug interaction example

A

Metabolism of warfarin is increased by some antibiotics meaning the INR becomes reduced (blood is thicker, clots easier), and the drug provides inadequate anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

drug-dietary supplement interaction examples

A

prescriptions, OTCs, illicit substances
St johns worts and many drugs
cocaine and antihypertensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what can drug-food or drink interaction cause? what are two examples?

A

-may cause interaction or prevent appropriate absorption
- doxyycline and milk
- metronidazole and alcohol ( get red in face, feeling very off)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

drug-disease interaction examples

A

-some drugs are helpful in one disease but harmful in others
- some beta blockers and asthma
-NSAIDs and heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what does A rated drug interaction severity mean (category, action, explanation)

A

category- unknown
action- no known interaction
explanation- no documentation of interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does B rated drug interaction severity mean (category, action, explanation)

A

category- minor
action- no action needed
explanation- limited clinical side effects, may increase frequency or severity of side effects but generally does not require a major change in therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does C rated drug interaction severity mean (category, action , explanation)

A

category- moderate
action- monitor therapy
explanation- may result in exacerbation of patients condition and/or require therapy alteration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does D rated drug interaction severity mean (category, action, explanation)

A

category- major
action- consider therapy modification
explanation- may be life threatening and/or require medical intervention to minimize or prevent serious adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does X rated drug interaction severity mean (category, action, explanation)

A

category- contraindicated
action- avoid combination
explanation- the drugs are contraindicated for concurrent use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pharmacodynamic drug interaction classification

A

-involves process or change of drugs
- interactions at receptor level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

pharmacokinetic drug interaction classification

A

-involves motion of drug through body
- interactions drug moving through body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are additive effects on same receptor (PD drug interaction) and an example drug and effect

A
  • multiple agonists working on similar receptors = excessive effect

-multiple benzodiazepines (ativan, xanax)
-excessive sedation, breathing issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are additive effects on different receptors (PD drug interaction) and example drugs and effect

A

-different agonists work on different receptors with similar adverse effects (causing the same result)

-benzodiazepines and opiods
= excess respiratory depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PD additive interactions causing increased bleeding risk

A
  • anticoagulants (warfarin, DOACs)
  • antiplatelets (clopidogrel, ticagrelor, prasugrel, aspirin)
  • NSAIDs, SSRIs, SNRIs
  • natural products (garlic, ginko, ginger, ginseng, glucosamine)
  • all these have an increased risk of bleeding but excess when taken together
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

PD additive interactions causing anticholinergic toxicity, and what are the side effects of this

A

-antihistamines ( diphenhydramine)
- SSRIs, antipsychotics, tricylic antidepressants
- muscle relaxants (baclofen)
- overactive bladder antimuscarinics (oxybutynin)

  • may not have side effect symptoms until given more than one of these together

side effects= dry mouth, dry eyes, urinary retention, constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PD additive interaction causing nephrotoxicity

A

-amnioglycosides, vancomyocin, amphotericin B
- NSAIDs
- IV loop diuretics
- chemotherapy (cisplatin, methotrexate) cyclosporine, tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

PD additive interaction causing QT prolongation examples

A
  • antiarrythmitics- amiodarone, sotalol, dofetilide, ibutilide, procainamide, dronedarone
  • antimicrobials- azoles, fluorquinoles, macrolides

-antipsychotics- haloperidol, quetiapine, ziprasidone

  • antidepressants- SSRIs, SNRIs, TCAs

-methandone, sumatriptan, ondansetron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PD additive interactions of serotonergic agents examples

A
  • mood-altering meds SSRIs, SNRIs, mirtazapine, trazadone, buspirone, TCAs, MAOi, lithium
  • linezolid
    -tramadol, methadone, meperidine
  • dextromethorphan
  • antiemetics (ondansetron)
  • triptans (sumatriptan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

PD additive interaction of hyperkalemia examples

A
  • excess potassium
  • ACE inhibitors, ARBs, sacubitril/valsartan
  • K- sparing diuretics
  • aldosterone antagonists
  • sulfamethoxazole/ trimethoprim
  • tacrolimus, cyclosporine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what are synergistic effects (PD interaction) and example

A

-effect of two drugs magnified beyond what would be expected

  • aminoglycosides and penicillins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what are antagonist blocking agonist effects (PD interaction) and example

A

-antagonist blocks and prevents further activation of receptor
-naloxone for opioid overdose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Chelation, complex formation, disruption of PK Absorption with drug interactions

A

-antacids, multivitamins reduce availability of fluroquinolone, tetracycline
- cholestyramine binds warfarin, sulfamethoxazole in small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

change in PH disruption in PK absorption with drug interactions

A
  • increasing pH of stomach (H2 antagonists, PPI, antacids) may decrease absorption of drugs that need acidic environments (itraconazole, ketoconazole)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

increased motility time, disruption of PK absorption example

A
  • metoclopramide increases gastric emptying, may reduce digoxin levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

4th way absorption (PK) is affecte din drug interaction without example ( and list the other three as well)

A

P- glycoprotien efflux pumps

( chelation- complex formation, change in pH, increased motility time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

PK Distribution effects from drug interactions

A

binding to alpha 1- acid glycoprotein and binding to albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

binding to albumin example- PK distribution disruption

A

diclofenac has same affinity for albumin as warfarin
- displacement of warfarin, increasing plasma concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

how is phase 1 metabolism affected in PK metabolism with drug interaction

A

-oxidation, reduction, hydrolysis for inactivation
- includes cytochrome P450 enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

how is phase 2 metabolism affected in PK metabolism with drug interaction

A

-glucuronidation, sulfation, methylation for elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

how is competition for transport in PK elimination affected in drug interaction

A

-probenecid blocks penicillin renal excretion, increasing therapeutic levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

how is change in urinary pH in PK elimination affected in drug interaction

A

-bicarbonate alkalizes urine, increases methotrexate excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what are cytochrome (CYP) P450 enzymes and how many are identified and primary break down drugs

A
  • hemeoproteins located in liver
  • more than 50 identified, 6 primary break down drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

small polymorphisms lead ______

A

changes in metabolism
- poor v extensive v ultrametabolizers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

drugs can be ____

A

substrates, inducers, inhibitors

41
Q

what are CYP inducers

A

-increase enzyme activity and metabolism
- often reduce amount of active drug available
- full effect may take days to weeks
— require new enzyme production
— washout period may be lengthened

42
Q

SCRAP GPS’S

A

S- sulfonylureas
C- carbazaepine (anti seizure)
R- rifampin and rifabutin (antibiotic)
A- alchohol use (chronic)
P- phenoarbital (anti seizure)
G- griseofulvin
P- phenytoin (anti seizure)
S- smoking
S- st johns wort

43
Q

what are CYP inhibitors

A
  • reduce enzymnatic activity and metabolism
  • often increase active drug availability (by inhibiting enzymes breakdown)
  • effects noted quickly (prolonged breakdown-x prolonged drug effect- possible side effects quicker)
  • can be used therapeutically - ritonavir, cobiccistat
44
Q

PACMAN’S GM ( grandma -slow- inhibitors)

A

P- protease inhibitors (cancer)
A- amiodarone
C- cyclosporine, chlorophenol, cimetidine
M- macrolides (not azithromyocin) (antibiotics)
A-azoles (anti fungals)
N- non DHP calcium channel blockers
S- sodium valproate (anti seizure)
G- grapefruit juice
M- metronidazole

45
Q

3A4 (enzyme) substrates

A

-analgesics ( buprenorphine, tramadol)
- anticoagulants (warfarin)
- antiplatelets (ticagelor)
- antidiabetics (saxigliptin)
- cardiovascular drugs (amiodorine)
- immunosuppressants (tacrolimus)
- statins (atorvastatin)
- HIV drugs (ritonavir)
-PDE-5 inhibitors (sildenafil)
-others (benzos, buspirone)

46
Q

2C8/9 (enzyme) substrates

A

amiodarone, pioglitazone, carvedilol, alosetron, celecoxib, diazepam, glyburide, glipizide, glimepiride, phenytoin, warfarin, ramelteon, zolpidem

47
Q

2C19 (enzyme) substrates

A

clopidogrel, phenytoin, voriconazole

48
Q

2D6 (enzyme) substrates

A
  • analgesics ( codeine, oxy)
  • antidepressants/ antipsychotics ( doxepin)
  • others ( carvedilol, tamoxifen)
49
Q

key point: many drugs affected by _____ enzymes

A

CYP450 enzymes

50
Q

a pt is taking fluconazole (for prophalaxis of AML) and developed MDD for which he was prescribed citalopram 40mg - what will occur with this reaction

A

fluconazole is a CYP inhibitor so it slows CYP enzyme so you dont get as much of the inactive metabolite fro citalopram - more citalopram available in the body - additive effect of QT prolongation

*prolonged QTc

51
Q

a patient was in hospital due to STEMI, got two stents placed in cath lab and has sicne started aspirin and ticagrelor (to keep stent open). He also started OTC st johns wort 2 weeks before MI- what could the implications be

A

st johns wort is a cyp inducer - adds an extra enzyme so breaks drug down faster so there will be increased risk of thrombosis as the stent wont be able to stay as open

52
Q

to monitor or to take action in drug interactions

A

important to consider implication of interaction
- if one is way higher priority and for known causes besst to keep that and discontinue others
-some cases not very clear
- consider each interaction and make clinical decision based on best judgement

53
Q

pt has PMH of hypolipedemia (HDL) being treated with atorvastatin, he recently got a juicer and makes grapefruit juice - what are the possibel implications of this new habit

A

grapefruit juice is a cyp inhibitor so in is going to make metabolism slower

increased risk of muscle aches (side effect of statins)

increased atorvastatin levels

54
Q

what percent of drugs are metabolized by non CYP enzymes? what kind of reaction is it?

A

33% of top 200 drugs

mainly by phase II elimination

55
Q

two facts about non cyp p450 enzymes

A

drug interactions less common

isoniazid toxicity can occur through some pathways

56
Q

3 examples of non cyp p450 enzymes

A

UDP- glucuronosyl transferase (UGT)
N- acytytransferase (NAT)
Monoamine oxidase (MAO)

57
Q

where are P-glyxoprotein (PGP) Efflux pumps found and what is their role

A

found around the body
pump substrates to prevent activity (OAT efflux pumps)

58
Q

p-glycoprotein efflux pump substrates

A
  • anticoagulants ( apixaban, rivaroxaban, dabigatran)
  • antineoplastics ( docetaxel, vincristine)
    -immunosupressants (cyclosporin, tacrolimus)
  • macrolides (clarithromyocin)
    -HIV drugs (dolutegravir)
    -digoxin
59
Q

p-glycoprotein efflux pump inducers

A

-st johns wort
- rifampin
- carbamazepine
- phenytoin
- phenobarbital

60
Q

p-glycoprotein efflux pump inhibitors

A
  • antibiotics (clarithromyocin, itraconazole, posaconazole)
  • HIV drugs (cobicistat, ritonavir)
    -cardio drugs ( verapamil, amiodarone, dronedarone, dilitiazem)
    -cyclosporine, ticagrelor
61
Q

67 YOF w PMH of T2DM, HTN, on metformin, lisinopril, verapamil recently developed Afib and was prescribed dabigatran
what is the risk associated with this drug interaction adn are there potential alternatives

A

dabigatran is an anticoagulant so there is an increased risk of bleeding due to the use of a p-gp inhibitor (veraprimil)

could switch and use different agents

62
Q

what is a prodrug, what do they use to activate, what do they risk

A
  • utilize CYP enzyme to activate drug
    (first pass metabolism)
    -can be used to increase bioavailability, avoid drug abuse
  • risk lack of activity or potential toxicity
63
Q

what is first pass metabolism in prodrugs

A

converts mediation to pharmacologically active formulation (must occur to have an effect)

64
Q

metabolite of codeine

A

morphine

65
Q

Metabolite of clopidogrel

A

active metabolite

66
Q

metabolite of lisdexamphetamine

A

dexamphetamine

67
Q

metabolite of fosphenytoin

A

phenytoin

68
Q

metabolite of enalapril

A

enalaprilat

69
Q

metabolite of valacyclovir

A

acyclovir

70
Q

metabolite of cortisone

A

cortisol

71
Q

metabolite of prednisone

A

predisolone

72
Q

metabolite of primidone

A

phenobarbital

73
Q

metabolite of tramadol

A

active metabolite

74
Q

metabolite of levadopa

A

dopamine

75
Q

metabolite of diazepam

A

oxazepam

76
Q

how is codeine converted to morphine
how does it affect UM and PM

A

converted via CYP2D6
UM- potential toxicity
PM (or patients taking CYP2D6 inhibitor)- lack of pain relief

77
Q

how is clopidogrel converted to active metabolite
how does it affect PM
what can be used alternatively for PM

A

converted via CYP2C19
PM- reduced platelet inhibition( bc drug not getting activated); use alternative P2Y12 inhibitor

78
Q

what are CYP2C19 inhibitors

A

reduce platelet inhibition; avoid combination with clopidogrel
omeprazole
esomeprazole

79
Q

narrow therapeutic index drugs

A

aminoglycosides
vancomyocin
digoxin
warfarin
tacrolimus
mycophenolate
cyclosporine
phenytoin
valproic acid
carbamazepine
theopylline
lithium
levothyroxine

80
Q

what is one of the most noted medications effected by drug interactions

A

warfarin

81
Q

metabolic interactions with warfarin

A

-substrate of CYP 2C9
- CYP3A4, CYP1A2, CYP2C19 also play a role

82
Q

vitamin K interactions of warfarin

A

-prescription meds
- OTC products
- foods

83
Q

what drugs increase bleeding risk of warfarin

A

anticoagulants, antiplatelets
NSAIDs
SSRIs

84
Q

what drugs increase metabolism interference of warfarin

A

ABCDEF
rifampin

85
Q

what drugs have a reduced vitamin k production by gut flora when taken with warfarin

A

antibiotics

86
Q

what drugs interrupt vitamin K cycle when taken with warfarin

A

acetaminophen (1.5-2.5 g chronically)

87
Q

Common drugs that change warfarin metabolism from highest INR to lowest INR

A

A- amiodarone (highest INR-thinnest blood)
B- bactrim
C- cipro (and other FQ)
D- diflucan (and other azoles)
E- erythromyocin (and other macrolides)
F- flagyl
(all above inhibit warfarin breakdown, prolonging activity)

R- rifampin (only one that decreases INR- inducer- thicker blood)

88
Q

effects of warfarin and amiodarone interaction (commonly seen)

A

decrease warfarin brekadown
increase bleeding
increase INR

89
Q

if already on amiodarone and starting warfarin what shoudl you do to the dose

A

reduce starting dose of warfarin by 30-50%

90
Q

if already on warfarin and starting amiodarone what should you do to the dose

A

reduce warfarin dose by about 50%

91
Q

amiodarone and digoxin interaction

A

used to control rate and rhythm in patients with Afib
digoxin is a p-gp substrate and amiodarone is a p-gp inhibitor

gives a risk of digoxin toxicity, reduced HR, electrolyte abnormalities

92
Q

if on amiodarone, used first, and starting digoxin, what should you do to the dose

A

start digoxin at a lower dose

93
Q

if on digoxin, used first, and starting amiodarone what should you do to the dose

A

decrease digoxin dose by 50%

(so basically always decrease digoxin with amiodarone because amiodarone can prolong activity of digoxin)

94
Q

what are carbamazepine and lamotrigine and what happens when used together

A

they are antiepileptics
carbamazepine is an enzyme inducer and lamotrigine is a substrate

used together you risk breakthrough seizures - start at a higher dose

95
Q

what are lamotrigine and valproic acid and what happens when used together

A

lamotrigine is a substrate and valproic acid is an enzyme inhibitor

risk lamotrogine toxicity (serious skin reactions) - start at lower dose

(becasue you have extended exposure of lamotrigine due to inhibition of its breakdown)

96
Q

pde-5 inhibitors (give examples) and nitrates (give examples) side effects when used together

A

pde-5 inhibitors like sildenafil and tadalafil
nitrates like nitroglycerin and isosorbide

cause excessive vasodilation and severe hypotension

concomitant use is CONTRAINDICATED

even PRN nitrates

97
Q

when should you check for drug interactions

A

any new medications
any medications on list that give you red flags
any med on pt list with narrow TI
any new adverse effects that may be additive

98
Q

clinical impact of drug interactions to consider

A

are there a lot of potential drug interactions
are they all clinically relevant (is someone drinking 15L of grapefruit juice to cause an interaction)
when do drug interactions require action ( based on clinical judgement)

99
Q
A